Market research reports, consulting: Global Market Insights Inc.

Home > Healthcare > Pharmaceuticals > Finished Drug Form > sirolimus market

Sirolimus Market Share

Report ID: GMI8726 Published Date: March 2024Report Format: PDF
Download Free Sample
Summary
Table of Content

Sirolimus Market Share

The sirolimus  industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products and services based on different technologies is among a key market strategy. Some of the leading industry players have a notable presence in the market.

Sirolimus Market Companies

Some of the eminent market participants operating in the sirolimus industry include:      

  • Accord Healthcare Limited                                  
  • Apotex Inc.                                  
  • Amneal Pharmaceuticals, Inc.                            
  • Actiza Pharmaceutical Private Limited                 
  • Biocon Limited                              
  • Concept Medical       
  • Concord Biotech                           
  • Dr. Reddy's Laboratories Ltd.                             
  • Intas Pharmaceuticals Ltd.                      
  • Livzon Pharmaceuticals Group Inc.                     
  • Pfizer Inc.                                    
  • Tiefenbacher API + Ingredients GmbH & Co. KG  
  • Torrent Pharmaceuticals Ltd.                              
  • Zydus Group   
Author: Mariam Faizullabhoy, Gauri Wani
Frequently Asked Question(FAQ) :

Who are the key leaders in the sirolimus industry?+

Apotex Inc., Concord Biotech, Dr. Reddy's Laboratories Ltd., Intas Pharmaceuticals Ltd., Livzon Pharmaceuticals Group Inc., Pfizer Inc., Tiefenbacher API + Ingredients GmbH & Co. KG, Torrent Pharmaceuticals Ltd., and Zydus Group, are some of the major sirolimus companies worldwide.

What is the size of the North America sirolimus market?+

North America sirolimus industry exceeded 109.7 million in 2023 due to the presence of state-of-the-art medical facilities, research institutions, and pharmaceutical companies in the region.

Why is the use of sirolimus in organ transplant rejection growing?+

The organ transplant rejection segment recorded USD 120.8 million in 2023 and is expected to register an appreciable CAGR from 2024-2032 due to its immunosuppressive properties and anti-proliferative effects on vascular smooth muscle cells.

How big is the sirolimus industry?+

Sirolimus market size crossed USD 270.7 million in 2023 and is expected to reach over USD 370.4 million by 2032 owing to the increasing prevalence of organ transplants and promising pipeline for different indications worldwide.

Sirolimus Market Scope

Related Reports

Buy Now

Buy Now

Premium Report Details

Download Free Sample